Institute of Biomedicine for Brazilian Semiarid, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.
Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Brazil.
BMJ Open. 2021 May 21;11(5):e043959. doi: 10.1136/bmjopen-2020-043959.
INTRODUCTION: Intestinal barrier function is dependent on the structure and function of intestinal epithelial cells and paracellular pathway. The derangement of the intestinal barrier function can originate from conditions involving local and systemic chronic inflammation and metabolic diseases such as obesity and metabolic disorders. This study aims to describe a systematic review protocol investigating if obesity with or without metabolic syndrome is associated with an altered intestinal barrier function. METHODS AND ANALYSIS: This protocol is guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. The databases to be searched are PubMed, Embase, Scopus, Science Direct and Web of Science. The systematic review will include original articles with adults and the elderly, who present obesity with or without metabolic syndrome, that address the intestinal barrier function. Two independent reviewers will perform study selection, data extraction and methodological quality assessment. Key information will be tabulated and a narrative synthesis will be conducted. The Grading of Recommendation, Assessment, Development and Evaluation framework will be used to assess the quality of evidence concerning the associations between intestinal barrier function and obesity with or without metabolic syndrome. The present protocol will assist in producing a systematic review that addresses if obesity with or without metabolic syndrome alters intestinal barrier function. ETHICS AND DISSEMINATION: No ethical statement will be required. The results will be disseminated through a peer-reviewed publication and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42020178658.
简介:肠道屏障功能依赖于肠道上皮细胞的结构和功能以及细胞旁途径。肠道屏障功能障碍可能源于涉及局部和全身慢性炎症以及代谢性疾病(如肥胖和代谢紊乱)的情况。本研究旨在描述一项系统评价方案,探讨肥胖伴或不伴代谢综合征是否与肠道屏障功能改变有关。
方法和分析:本方案遵循系统评价和荟萃分析报告的首选条目。将搜索的数据库包括 PubMed、Embase、Scopus、Science Direct 和 Web of Science。系统评价将包括有成年人和老年人的原始文章,他们患有肥胖伴或不伴代谢综合征,并解决肠道屏障功能问题。两名独立的审查员将进行研究选择、数据提取和方法学质量评估。关键信息将制成表格,并进行叙述性综合。将使用推荐评估、发展和评估分级框架来评估与肥胖伴或不伴代谢综合征相关的肠道屏障功能之间的关联的证据质量。本方案将有助于进行系统评价,以确定肥胖伴或不伴代谢综合征是否改变肠道屏障功能。
伦理和传播:不需要伦理声明。结果将通过同行评审的出版物和会议报告进行传播。
PROSPERO 注册号:CRD42020178658。
Am J Physiol Gastrointest Liver Physiol. 2020-9-9
Int J Clin Pract. 2019-7-5
Am J Physiol Gastrointest Liver Physiol. 2019-5-24
Nat Rev Endocrinol. 2019-5